Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001130166-04-000017
Filing Date
2004-11-04
Accepted
2004-11-04 13:19:05
Documents
1
Period of Report
2004-11-03

Document Format Files

Seq Description Document Type Size
1 wer9.html 4  
1 wer9.xml 4 4887
  Complete submission text file 0001130166-04-000017.txt   6581
Mailing Address
Business Address 1124 COLUMBIA STREET SUITE 130 SEATTLE WA 98104 2062626200
XCYTE THERAPIES INC (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 123 W MILLS EL PASO TX 79901
Business Address 123 W MILLS EL PASO TX 79901 915 543 5711
WERTHEIMER STEPHEN (Reporting) CIK: 0001186799 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 041118882